The IBD SmartSelect Composite Rating for Salesforce rose from 94 to 96 Friday.
The upgrade means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
Salesforce stock is not currently near a proper entry. The Stock is trying to clear key moving averages as it fights back from recent lows. See if the stock goes on to form a new chart pattern and offer a new buying opportunity.
See IBD's Upcoming Earnings Calendar, Updated Weekly
The stock has a 98 EPS Rating, which means its recent quarterly and annual earnings growth tops 98% of all stocks.
Its Accumulation/Distribution Rating of C- shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q2, the company reported 78% earnings growth. Revenue was flat, matching the prior report's 11%. Next report is due Nov. 28.
Salesforce earns the No. 9 rank among its peers in the Computer Software-Enterprise industry group. ServiceNow, UiPath and Palantir Technologies are among the top 5 highly-rated stocks within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks